Overview

Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer

Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the effects of metformin in addition to the conventional progestin therapy in the fertility-sparing treatment of early stage endometrial cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Metformin